1. Home
  2. PCT vs IRWD Comparison

PCT vs IRWD Comparison

Compare PCT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

N/A

Current Price

$1.72

Market Cap

556.5M

Sector

Utilities

ML Signal

N/A

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.83

Market Cap

578.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCT
IRWD
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
556.5M
578.3M
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
PCT
IRWD
Price
$1.72
$4.83
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $6.40
$6.18
AVG Volume (30 Days)
★ 8.6M
2.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.86
N/A
EPS
N/A
★ 0.91
Revenue
$8,355,000.00
★ $298,276,000.00
Revenue This Year
$269.48
$59.19
Revenue Next Year
$262.99
$4.80
P/E Ratio
★ N/A
$5.33
Revenue Growth
N/A
★ 8.88
52 Week Low
$1.60
$2.95
52 Week High
$14.20
$5.78

Technical Indicators

Market Signals
Indicator
PCT
IRWD
Relative Strength Index (RSI) 26.91 76.30
Support Level $1.60 $3.90
Resistance Level $3.53 N/A
Average True Range (ATR) 0.35 0.24
MACD -0.03 0.16
Stochastic Oscillator 6.20 93.10

Price Performance

Historical Comparison
PCT
IRWD

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: